EurekAlert! -
8 Dec 2013 07:00
(Wellcome Trust Sanger Institute) Scientists propose that a gene that is mutated in one per cent of cancer patients could offer a new avenue to personalised cancer therapy. The team used data from thousands of cancer patients to find that the CUX1 gene is mutated at a low frequency over a wide range of cancer types. Drugs that could be effective against this cancer causing mutation are currently available.
Share this Article